发明名称 |
Forma de dosificacion oral que comprende una dispersion del compuesto (2-(1s)-1-(3-etoxi-4-metoxi-fenil)-2-metanosulfonil-etil)-3-oxo-2,3-dihidro-1h-isoindol-4-il)-amida del acido ciclopropanocarboxilico y su uso en el tratamiento y prevencion del cancer, dolor, degeneracion macular, entre otras enfermedades. |
摘要 |
<p>Pharmaceutical compositions and single unit dosage forms of {2-[(IS)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindo1-4-yl}-amide, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate thereof, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.</p> |
申请公布号 |
CL2014000623(A1) |
申请公布日期 |
2014.11.07 |
申请号 |
CL20140000623 |
申请日期 |
2014.03.14 |
申请人 |
CELGENE CORPORATION |
发明人 |
BOERSEN, NATHAN;LEE, WAI YIP;HUI, HO-WAH;KURTULIK, PAUL |
分类号 |
A61K9/14;A61K9/20;A61K31/403;A61P35/00 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|